observation group:observation

5 trials

Sponsors

Nanyang Central Hospital, He'nan, Department of Thoracic Surgery, the First Medical Center of PLA General Hospital, West China Hospital, Sichuan University, Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Conditions

NSCLCcancerlung cancernon-small cell lung cancer

Phase 4

A randomized controlled clinical study to assess the effects of icotinib as adjuvant therapy in patients with EGFR mutation and MRD-positive stage IA2-IB non-small cell lung cancer

Active, not recruitingChiCTR2300070717

West China Hospital, Sichuan Universitylung cancer

Start: 2023-04-21Updated: 2023-06-04

Unknown Phase

The demonstration and promotion of Traditional Chinese Medicine clinical guidelines for lung cancer: Curative effect observation on intervention of Ttaditional Chinese Medicine sport Baduanjin on postoperative non-small cell lung cancer patients

RecruitingChiCTR-OOC-14005430

Guang'anmen Hospital, China Academy of Chinese Medical SciencesNSCLC

Start: 2014-09-01Updated: 2017-04-18

The demonstration and promotion of Traditional Chinese Medicine clinical guidelines for lung cancer: curative effect observation of comprehensive psychological intervention on cancer patients with psychological disorder

RecruitingChiCTR-OOC-14005431

Guang'anmen Hospital, China Academy of Chinese Medical Sciencescancer

Start: 2014-09-01Updated: 2017-04-18

To explore the curative effect of Corbrin Capsule and influencing factors of proteinuria caused by Apatinib: A prospective randomized controlled study

RecruitingChiCTR1800014662

Nanyang Central Hospital, He'nancancer

Start: 2016-12-20Updated: 2018-01-29

Screening of adjuvant therapy for stage IB non-small cell lung cancer under different staging system

RecruitingChiCTR2200060931

Department of Thoracic Surgery, the First Medical Center of PLA General Hospitalnon-small cell lung cancer

Start: 2019-07-01Updated: 2023-03-26